Haermonics is a clinical stage medtech company focused on preventing blood-related complications post open-heart surgery. The company's main offering is an innovative flush-therapy system designed to continuously clean the pericardial space, thereby preventing complications such as residual blood and clots. Haermonics primarily serves the healthcare industry, specifically the cardiac surgery sector. It is based in Amsterdam, Netherlands.
Latest Haermonics News
Oct 3, 2023
Haermonics Frequently Asked Questions (FAQ)
Where is Haermonics's headquarters?
Haermonics's headquarters is located at Amsterdam.
What is Haermonics's latest funding round?
Haermonics's latest funding round is Series A.
How much did Haermonics raise?
Haermonics raised a total of $4.38M.
Who are the investors of Haermonics?
Investors of Haermonics include BOM Brabant Ventures, NLC and Demcon.